Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SEQUENT SCIENTIFIC vs SUVEN PHARMACEUTICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SEQUENT SCIENTIFIC SUVEN PHARMACEUTICALS SEQUENT SCIENTIFIC/
SUVEN PHARMACEUTICALS
 
P/E (TTM) x -23.3 46.4 - View Chart
P/BV x 4.5 9.9 45.1% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 SEQUENT SCIENTIFIC   SUVEN PHARMACEUTICALS
EQUITY SHARE DATA
    SEQUENT SCIENTIFIC
Mar-23
SUVEN PHARMACEUTICALS
Mar-23
SEQUENT SCIENTIFIC/
SUVEN PHARMACEUTICALS
5-Yr Chart
Click to enlarge
High Rs156629 24.8%   
Low Rs62388 15.9%   
Sales per share (Unadj.) Rs57.052.7 108.2%  
Earnings per share (Unadj.) Rs-4.916.2 -30.3%  
Cash flow per share (Unadj.) Rs-2.718.0 -14.7%  
Dividends per share (Unadj.) Rs06.00 0.0%  
Avg Dividend yield %01.2 0.0%  
Book value per share (Unadj.) Rs25.868.2 37.8%  
Shares outstanding (eoy) m249.43254.57 98.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.99.7 19.8%   
Avg P/E ratio x-22.331.5 -70.8%  
P/CF ratio (eoy) x-41.028.2 -145.3%  
Price / Book Value ratio x4.27.5 56.7%  
Dividend payout %037.1 -0.0%   
Avg Mkt Cap Rs m27,151129,395 21.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2,5841,105 233.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m14,20913,403 106.0%  
Other income Rs m64464 13.8%   
Total revenues Rs m14,27313,867 102.9%   
Gross profit Rs m-5285,739 -9.2%  
Depreciation Rs m557477 116.7%   
Interest Rs m355128 277.2%   
Profit before tax Rs m-1,3775,597 -24.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1571,484 -10.6%   
Profit after tax Rs m-1,2204,113 -29.7%  
Gross profit margin %-3.742.8 -8.7%  
Effective tax rate %11.426.5 43.0%   
Net profit margin %-8.630.7 -28.0%  
BALANCE SHEET DATA
Current assets Rs m8,12511,554 70.3%   
Current liabilities Rs m5,5883,031 184.4%   
Net working cap to sales %17.963.6 28.1%  
Current ratio x1.53.8 38.1%  
Inventory Days Days21148 14.3%  
Debtors Days Days88302 29.0%  
Net fixed assets Rs m7,4359,547 77.9%   
Share capital Rs m499255 196.0%   
"Free" reserves Rs m5,92617,097 34.7%   
Net worth Rs m6,42517,352 37.0%   
Long term debt Rs m1,82846 4,005.3%   
Total assets Rs m15,66121,101 74.2%  
Interest coverage x-2.944.7 -6.4%   
Debt to equity ratio x0.30 10,817.6%  
Sales to assets ratio x0.90.6 142.8%   
Return on assets %-5.520.1 -27.5%  
Return on equity %-19.023.7 -80.1%  
Return on capital %-12.432.9 -37.6%  
Exports to sales %1.80-   
Imports to sales %1.00-   
Exports (fob) Rs m255NA-   
Imports (cif) Rs m138NA-   
Fx inflow Rs m25514,672 1.7%   
Fx outflow Rs m1381,848 7.5%   
Net fx Rs m11712,824 0.9%   
CASH FLOW
From Operations Rs m1684,509 3.7%  
From Investments Rs m-650-1,948 33.3%  
From Financial Activity Rs m322-2,358 -13.7%  
Net Cashflow Rs m-159202 -78.7%  

Share Holding

Indian Promoters % 0.0 9.9 -  
Foreign collaborators % 52.8 50.1 105.4%  
Indian inst/Mut Fund % 13.3 26.1 51.1%  
FIIs % 6.1 10.1 60.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 47.2 40.0 118.0%  
Shareholders   172,853 70,052 246.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SEQUENT SCIENTIFIC With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SEQUENT SCIENTIFIC vs SUVEN PHARMACEUTICALS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SEQUENT SCIENTIFIC vs SUVEN PHARMACEUTICALS Share Price Performance

Period SEQUENT SCIENTIFIC SUVEN PHARMACEUTICALS S&P BSE HEALTHCARE
1-Day -3.72% 5.78% 1.18%
1-Month -12.68% 5.21% -0.75%
1-Year 70.74% 44.00% 61.82%
3-Year CAGR -21.73% 12.19% 18.16%
5-Year CAGR 9.54% 32.13% 19.79%

* Compound Annual Growth Rate

Here are more details on the SEQUENT SCIENTIFIC share price and the SUVEN PHARMACEUTICALS share price.

Moving on to shareholding structures...

The promoters of SEQUENT SCIENTIFIC hold a 52.8% stake in the company. In case of SUVEN PHARMACEUTICALS the stake stands at 60.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SEQUENT SCIENTIFIC and the shareholding pattern of SUVEN PHARMACEUTICALS.

Finally, a word on dividends...

In the most recent financial year, SEQUENT SCIENTIFIC paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

SUVEN PHARMACEUTICALS paid Rs 6.0, and its dividend payout ratio stood at 37.1%.

You may visit here to review the dividend history of SEQUENT SCIENTIFIC, and the dividend history of SUVEN PHARMACEUTICALS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.